Company analysis: BASF
Company Analysis: BASF
HOLD balances improved earnings visibility with unresolved cash-conversion risk. BASF upgraded 2026 EBITDA before special items guidance to €6.9–€7.7bn and 1H 2026 showed tangible volume/price recovery and higher EBITDA before special items (€4.8bn). (basf.com) However, free cash flow has been negative in 1H 2026 (-€1.6bn) and Q2 was expected at -€0.2bn due to working-capital pressure from higher raw material prices, while full-year FCF guidance remains €1.5–€2.3bn—making 2H execution critical. (basf.com) With the stock near €52.28 (Oct 22, 2026) and consensus target price averaging €53.60, risk/reward appears balanced until Q3/2H data confirm cash normalization and sustained operating momentum. (stockanalysis.com)
Summary
BASF SE is a diversified chemicals group with an integrated “Verbund” production model (shared feedstocks, energy and intermediates across sites) and a portfolio spanning Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The business model is cyclical and capital-intensive, with earnings driven by global industrial demand, energy/feedstock spreads, and pricing discipline; BASF’s scale, integration, and broad customer exposure are core competencies that can support resilience across cycles. In 1H 2026, BASF reported a clear operational improvement versus 1H 2025: sales increased to €33.2bn (+€1.9bn) on positive volume and price effects (volumes +5.7%, prices +4.8%), and EBITDA before special items rose to €4.8bn (+€715m), with particularly stronger contributions from Materials, Industrial Solutions, Chemicals and Surface Technologies. (basf.com) Management also highlighted accelerated cost and organizational measures, including ~7,000 headcount reductions worldwide from Jan 2024 to end-Jun 2026 (excluding divestiture effects and Zhanjiang build-up), and Ludwigshafen FTEs falling below 30,000 in May 2026. (basf.com) A key recent development was the closing of the Coatings divestiture to Carlyle on June 30, 2026, which drove a large disposal gain (pre-tax €3.9bn) and lifted Q2 net income to an expected €4.1bn (vs Vara consensus €2.4bn). (basf.com) However, cash conversion has been weaker near-term: Q2 2026 free cash flow was expected at -€0.2bn due to higher working capital tied up from higher raw material prices, and 1H 2026 free cash flow was -€1.6bn. (basf.com) On guidance, BASF increased its full-year 2026 EBITDA before special items outlook to €6.9–€7.7bn (from €6.2–€7.0bn), while maintaining free cash flow guidance of €1.5–€2.3bn for 2026. (basf.com) Near-term, investors should focus on whether the 1H volume/price recovery persists into 2H, and whether working-capital normalization supports the full-year free cash flow range. Valuation metrics (EUR, Oct 22, 2026) indicate a market cap ~€45.0bn and a spot P/E ~8.0x, with a forward P/E ~18.3x and EV/EBITDA ~8.1x (provider methodology dependent). (stockanalysis.com) Analyst consensus compiled by Vara Research and published by BASF shows an average target price of €53.60 (high €64, low €40). (basf.com) The medium-term outlook is anchored by the upgraded 2026 earnings range, execution of efficiency measures, and delivery of the €1.5–€2.3bn free cash flow target despite raw-material-driven working-capital volatility. (basf.com)
Key Takeaways
- Guidance improved: BASF raised 2026 EBITDA before special items to €6.9–€7.7bn while keeping 2026 free cash flow guidance at €1.5–€2.3bn. (basf.com)
- 1H 2026 showed operational recovery: sales €33.2bn (+€1.9bn YoY) with volumes +5.7% and prices +4.8%; EBITDA before special items €4.8bn (+€715m). (basf.com)
- Coatings divestiture materially affected reported earnings: Q2 net income expected €4.1bn, driven by a €3.9bn pre-tax disposal gain; this is non-recurring and should be separated from run-rate profitability. (basf.com)
- Cash conversion is the near-term debate: Q2 free cash flow expected -€0.2bn and 1H free cash flow -€1.6bn, largely due to working-capital effects from higher raw material prices. (basf.com)
- Market framing: Oct 22, 2026 valuation shows spot P/E ~8.0x vs forward P/E ~18.3x and EV/EBITDA ~8.1x; consensus target price averages €53.60. (stockanalysis.com)
Action Ideas
Data-driven upside case centered on upgraded 2026 earnings guidance and improving 1H operating trends. BASF raised 2026 EBITDA before special items to €6.9–€7.7bn, indicating stronger-than-expected business development, while 1H 2026 showed both volume (+5.7%) and price (+4.8%) tailwinds and a €715m YoY increase in EBITDA before special items to €4.8bn. The stock’s valuation snapshot (Oct 22, 2026) shows EV/EBITDA ~8.1x and forward P/E ~18.3x, and the Vara-compiled consensus target price averages €53.60, providing a benchmark for potential re-rating if cash conversion improves into year-end.
Horizon: 12 mo.
Base-case positioning for investors already exposed: maintain while monitoring cash conversion and confirmation of 2H run-rate. The company upgraded EBITDA guidance but maintained free cash flow guidance, explicitly citing higher capital tied up from higher raw material prices. With Q3 2026 written information scheduled for Oct 28, 2026, the next catalyst is evidence that the 1H recovery (sales/volume/price) continues and that working capital begins to normalize. Consensus targets (~€53.60 average) suggest limited near-term dislocation versus current levels (~€52.28 on Oct 22, 2026), supporting a wait-for-data stance.
Horizon: 6 mo.
Risk-reduction case focused on cash flow and normalization risk: despite improved 1H earnings, free cash flow has been negative in 1H 2026 (-€1.6bn) and Q2 (-€0.2bn expected). If an investor’s mandate prioritizes cash yield/visibility, the gap between earnings improvement and cash generation is a concrete concern. Additionally, Q2 reported net income strength was heavily influenced by the Coatings disposal gain, which does not repeat. A sell can be justified if the investor expects continued working-capital pressure and prefers to re-enter after evidence of sustained positive FCF trajectory within the €1.5–€2.3bn FY 2026 range.
Horizon: 3 mo.
Contrarian Insights
- • Consensus may be overly anchored to the headline earnings uplift from the Coatings disposal gain; the more decision-relevant variable for equity value over the next 6–12 months is whether BASF converts improved EBITDA into cash within the €1.5–€2.3bn 2026 free cash flow range, given 1H 2026 FCF of -€1.6bn and Q2 FCF expected -€0.2bn. (basf.com)
- • The market may be underweighting the operational significance of BASF’s cost/organizational actions (e.g., ~7,000 headcount reduction since Jan 2024 to end-Jun 2026 and Ludwigshafen FTEs below 30,000). If these measures structurally lower the cost base, BASF’s earnings sensitivity to mid-cycle demand could improve versus prior cycles, even if near-term cash flow remains volatile. (basf.com)
Sources (6)
- https://www.basf.com/global/en/media/news-releases/2026/07/p-26-132
- https://www.basf.com/global/en/investors/calendar-and-publications/service-for-shareholders/faq/reporting-q2-2026
- https://www.basf.com/global/en/investors/share-and-adrs/analysts/analyst-estimates
- https://www.basf.com/global/en/investors/calendar-and-publications/calendar/2026/third-quarter-results
- https://stockanalysis.com/quote/etr/BAS/financials/ratios/
- https://stockanalysis.com/quote/etr/BAS/forecast/